Equities research analysts predict that Sabra Health Care REIT, Inc. (NASDAQ:SBRA) will post sales of $153.54 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Sabra Health Care REIT’s earnings, with the lowest sales estimate coming in at $148.50 million and the highest estimate coming in at $156.10 million. Sabra Health Care REIT reported sales of $155.76 million in the same quarter last year, which indicates a negative year over year growth rate of 1.4%. The business is expected to announce its next earnings report on Monday, February 22nd.
On average, analysts expect that Sabra Health Care REIT will report full year sales of $602.59 million for the current year, with estimates ranging from $601.00 million to $605.30 million. For the next fiscal year, analysts anticipate that the business will post sales of $623.41 million, with estimates ranging from $611.20 million to $631.60 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that follow Sabra Health Care REIT.
Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Thursday, November 5th. The real estate investment trust reported $0.18 EPS for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.24). Sabra Health Care REIT had a net margin of 21.00% and a return on equity of 3.78%.
SBRA has been the subject of a number of research analyst reports. ValuEngine downgraded Sabra Health Care REIT from a “hold” rating to a “sell” rating in a research report on Tuesday, January 5th. Jefferies Financial Group raised Sabra Health Care REIT from a “hold” rating to a “buy” rating and increased their price target for the company from $17.00 to $20.00 in a research report on Wednesday. BidaskClub downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Friday, September 25th. Smith Barney Citigroup increased their price target on Sabra Health Care REIT from $14.00 to $17.00 in a research report on Tuesday, December 15th. Finally, Zacks Investment Research raised Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a report on Wednesday. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $17.64.
Institutional investors have recently bought and sold shares of the company. NEXT Financial Group Inc bought a new position in shares of Sabra Health Care REIT in the third quarter worth $37,000. CI Investments Inc. purchased a new stake in shares of Sabra Health Care REIT in the third quarter worth $39,000. Private Advisor Group LLC purchased a new stake in shares of Sabra Health Care REIT in the second quarter worth $60,000. Van ECK Associates Corp raised its position in shares of Sabra Health Care REIT by 23.5% in the third quarter. Van ECK Associates Corp now owns 6,196 shares of the real estate investment trust’s stock worth $85,000 after buying an additional 1,177 shares in the last quarter. Finally, Cetera Investment Advisers purchased a new stake in shares of Sabra Health Care REIT in the third quarter worth $140,000. 89.73% of the stock is owned by hedge funds and other institutional investors.
Shares of SBRA opened at $17.20 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $3.56 billion, a price-to-earnings ratio of 27.30 and a beta of 1.29. The stock has a 50 day moving average of $17.47 and a 200 day moving average of $15.43. Sabra Health Care REIT has a 12 month low of $5.55 and a 12 month high of $22.55.
About Sabra Health Care REIT
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing – LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing – ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing – Managed communities.
Further Reading: How are the companies in the S&P 500 selected?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.